“You have the opportunity to help one patient in front of you when you are a clinician, but when working in the laboratory you have the opportunity to help millions of patients when you make
In December 2018 the Australian Therapeutic Goods Administrator (TGA) approved the use of chimeric antigen receptor T cell (CAR-T cell) therapy for two types of blood cancer, diffuse large B cell lymphoma (DLBCL) and B
Genomics, genetics and epigenetics seem to be buzzwords in the medical research area, especially when it comes to finding new treatments and ways to attack cancer. Researchers talk about mutations, malfunctioning genes, over expressed genes
Just like every snowflake Snowdome Foundation is unique. We are the only organisation that is exclusively focused on funding blood cancer research to help Australian patients live a longer, better life. We are extremely proud of the
The 2018 ‘Bloody Good Dinner’ raised almost $740,000 for the Snowdome Foundation and Maddie’s Vision to direct towards essential research into blood cancer and bone marrow failure. One of the important projects that the Boards
Wonderful news for multiple myeloma patients with interim results of a new clinical trial (MAIA) reporting positive outcomes. Multiple myeloma patients who were not candidates for high dose chemotherapy or autologous stem cell transplants were
2016 Annual Review Our 2016 Annual Review (with 2015/2016 financials) is now available to view online. In less than seven years, the Snowdome Foundation has extended 24 grants representing over $14 million to Australian researchers and
Snowdome co-founder, Professor Miles Prince publishes a paper on impressive new research The Snowdome Foundation is proud to announce that blood cancer specialist, researcher and co-founder of Snowdome, Professor Miles Prince, has published a paper
What a Bloody Good Success! Last year, we celebrated the outstanding achievement and collaboration of Snowdome Foundation and Maddie Riewoldt’s Vision via winning the National Charity Telstra Business Awards. To continue and strengthen this partnership,
Snowdome is proud to partner with Vision Super to deliver the Vision Super-Snowdome Foundation Fellowship to expand access to genetic testing for blood cancer patients at Peter MacCallum Cancer Foundation and improve access to personalised cancer
